Step 1: Understanding the Concept:
This question is looking for a drug used in COPD whose mechanism involves inhibiting phosphodiesterase type 4, an enzyme that normally breaks down cyclic AMP inside airway cells.
Step 2: Key Formula or Approach:
Go through each drug class in the options and check whether phosphodiesterase inhibition is part of how it works.
Step 3: Detailed Explanation:
Montelukast blocks leukotriene receptors, cromoglicate stabilizes mast cells, and omalizumab binds free IgE, none of which touches phosphodiesterase enzymes.
Theophylline, a methylxanthine, works by inhibiting phosphodiesterase enzymes, including PDE4, which prevents the breakdown of cyclic AMP inside bronchial smooth muscle and inflammatory cells.
Raised cyclic AMP relaxes bronchial smooth muscle and dampens inflammatory cell activity, giving both a bronchodilator and an anti-inflammatory benefit in COPD.
This PDE4 inhibitory component is what sets theophylline apart from the other three options, none of which acts on phosphodiesterase at all.
Step 4: Final Answer:
Theophylline is the drug among the options whose mechanism includes PDE4 inhibition, and it is used in COPD.